Menu
Back to Journals » OncoTargets and Therapy » Volume 6
Review
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 20,461 | Dovepress* | 14,610+ | 3,551 | 18,161 | |
| PubMed Central* | 5,851 | 1,942 | 7,793 | ||
| Totals | 20,461 | 5,493 | 25,954 | ||
|
*Since 5 November 2013 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 0 | 0 | 0 | 0 | 5 |
View citations on PubMed Central and Google Scholar